Procoagulant activity of ascitic fluid in hepatic cirrhosis: in vivo and in vitro.
Three cases of disseminated intravascular coagulation following infusion of ascitic fluid from the peritoneal cavity to the vascular system are reported in patients with hepatic cirrhosis. One of these was treated with intermittent drainage and infusion, and in the other two a LeVeen shunt was used. Studies on the ascitic fluid indicate the presence of a procoagulant material which would appear to be an activator of factor X. Preactivated factor X (Xa) from the fluid and/or a tissue factor activator of factor VII are additional possibilities.
D000328:Adult; D001201:Ascites / Q000628:therapy*; D001202:Ascitic Fluid; D001777:Blood Coagulation; D001780:Blood Coagulation Tests; D004211:Disseminated Intravascular Coagulation / Q000209:etiology*; D005170:Factor X; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D008103:Liver Cirrhosis / Q000150:complications*; D008297:Male; D008875:Middle Aged
D005170:Factor X